Skip to main content

Articles

Page 11 of 33

  1. Investigate the impact of interval cytoreductive surgery (ICS) on progression in an orthotopic mouse model of ovarian cancer and the impact of chemotherapy delivered at various timelines following surgery.

    Authors: Mitchell Clark, Alexandra Kollara, Theodore J. Brown and Taymaa May
    Citation: Journal of Ovarian Research 2021 14:157
  2. Polycystic ovary syndrome (PCOS) is an endocrine disease that increases the risk of infertility. Circular RNAs (circRNAs) play important roles in regulating the biological processes of PCOS. Our study was desi...

    Authors: Yongqian Chen, Jintian Miao and Ge Lou
    Citation: Journal of Ovarian Research 2021 14:156
  3. Circular RNAs (circRNAs) are increasingly recognized as important regulators in cancer including ovarian cancer (OC). This work focuses on the effects of circ_0000745 on the OC development of and molecules inv...

    Authors: Shengtan Wang, Zaihong Li, Genhai Zhu, Lan Hong, Chunyan Hu, Kang Wang, Kaiying Cui and Chunbo Hao
    Citation: Journal of Ovarian Research 2021 14:154
  4. Following cervical and uterine cancer, ovarian cancer (OC) has the third rank in gynecologic cancers. It often remains non-diagnosed until it spreads throughout the pelvis and abdomen. Identification of the mo...

    Authors: Kiarash Tanha, Azadeh Mottaghi, Marzieh Nojomi, Marzieh Moradi, Rezvan Rajabzadeh, Samaneh Lotfi and Leila Janani
    Citation: Journal of Ovarian Research 2021 14:153
  5. Mitochondrial injury in granulosa cells (GCs) is associated with the pathophysiological mechanism of polycystic ovary syndrome (PCOS). Melatonin reduces the mitochondrial injury by enhancing SIRT1 (NAD-depende...

    Authors: Bo Zheng, Junan Meng, Yuan Zhu, Min Ding, Yuting Zhang and Jianjun Zhou
    Citation: Journal of Ovarian Research 2021 14:152
  6. miR-146b-5p has been reported to participate in premature ovarian failure (POF) in mice. However, its role in POF patients is unclear. We predicted that miR-146b-5p might interact with lncRNA DLEU1, a crucial ...

    Authors: Caihong Zheng, Shiwei Liu, Zhihong Qin, Xiaoqian Zhang and Yubao Song
    Citation: Journal of Ovarian Research 2021 14:151
  7. ETS transcription factors are known to act as either positive or negative regulators of the expression of genes involved in various biological processes. It was reported that ETS variant transcription factor 5...

    Authors: Lu Zhang, Ruiting Fu, Ping Liu, Lijun Wang, Weihua Liang, Hong Zou, Wei Jia and Lin Tao
    Citation: Journal of Ovarian Research 2021 14:149
  8. Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) is the recommended approach in patients with advanced epithelial ovarian cancer (EOC). However, most patients eventually relapse des...

    Authors: M. Liontos, A. Andrikopoulou, K. Koutsoukos, C. Markellos, E. Skafida, O. Fiste, M. Kaparelou, N. Thomakos, D. Haidopoulos, A. Rodolakis, M. A. Dimopoulos and F. Zagouri
    Citation: Journal of Ovarian Research 2021 14:148
  9. Cryopreservation of ovarian tissue is a powerful technique for preserving female fertility, as it can restore fertility and endocrine function. To increase the longevity of the transplant and decrease the risk...

    Authors: Ana Sofia Pais, Sandra Reis, Mafalda Laranjo, Francisco Caramelo, Fátima Silva, Maria Filomena Botelho and Teresa Almeida-Santos
    Citation: Journal of Ovarian Research 2021 14:147
  10. Follicle stimulating hormone (FSH) is secreted by the anterior pituitary and acts on the germ cells indirectly through Granulosa cells in ovaries and Sertoli cells in the testes. Extragonadal action of FSH has...

    Authors: Deepa Bhartiya, Hiren Patel, Ankita Kaushik, Pushpa Singh and Diksha Sharma
    Citation: Journal of Ovarian Research 2021 14:145

    The Commentary to this article has been published in Journal of Ovarian Research 2021 14:146

    The Review to this article has been published in Journal of Ovarian Research 2021 14:144

  11. FSH was first identified in 1930 and is central to mammalian reproduction. It is indeed intriguing that despite being researched upon for about 90 years, there is still so much more to learn about FSH-FSHR bio...

    Authors: Deepa Bhartiya and Hiren Patel
    Citation: Journal of Ovarian Research 2021 14:144

    The Commentary to this article has been published in Journal of Ovarian Research 2021 14:146

    The Review to this article has been published in Journal of Ovarian Research 2021 14:145

  12. FOXL2 mutations in human cause Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES). While type II BPES solely features eyelid abnormality, type I BPES involves not only eyelid but also ovary, leadi...

    Authors: Yiqi Yu, Mengxia Ji, Weihai Xu, Ling Zhang, Ming Qi and Jing Shu
    Citation: Journal of Ovarian Research 2021 14:143
  13. Perfluorohexane sulfonate (PFHxS) is a six-carbon perfluoroalkyl sulfonic acid found as an environmental contaminant. This study aims to investigate the effects of PFHxS exposure on female reproduction and the...

    Authors: Xiaorui Yin, Tingting Di, Xinyuan Cao, Zhengnan Liu, Jingyan Xie and Suyun Zhang
    Citation: Journal of Ovarian Research 2021 14:141
  14. Poly (ADP)-ribose polymerase (PARP) inhibitors have entered routine clinical practice for the treatment of high-grade serous ovarian cancer (HGSOC), yet the molecular mechanisms underlying treatment response t...

    Authors: Alexandra Franz, Fabian Coscia, Ciyue Shen, Lea Charaoui, Matthias Mann and Chris Sander
    Citation: Journal of Ovarian Research 2021 14:140
  15. A frozen section diagnosis of a borderline ovarian tumor with suspicious features of invasive carcinoma (“at least borderline” or synonymous descriptions) presents us with the dilemma of whether or not to perf...

    Authors: Koen De Decker, Karina H. Jaroch, Joost Bart, Loes F. S. Kooreman, Roy F. P. M. Kruitwagen, Hans W. Nijman and Arnold-Jan Kruse
    Citation: Journal of Ovarian Research 2021 14:139
  16. Accumulating data have established that microRNAs (miRNAs) play significant regulatory roles in the carcinogenesis and progression of ovarian cancer (OC). MiR-425-5p was reported to function in various tumors. Ho...

    Authors: Zhihui Wu, Jianlin Guo, Ying Zhang, Jianhua Liu, Hongping Ma and Yurong Tang
    Citation: Journal of Ovarian Research 2021 14:138
  17. Mixed cell ovarian adenocarcinoma (MCOA) is a malignant gynecologic tumor consisting of serous, mucous, and papillary tumor cells. However, the clinical features and prognosis of MCOA patients are unclear.

    Authors: Huijie Wu, Shaotao Jiang, Peiwen Zhong, Weiru Li and Siyou Zhang
    Citation: Journal of Ovarian Research 2021 14:137
  18. Ovarian cancer is an aggressive tumor in women with high mortality. Paclitaxel (PTX) can be used for the chemotherapy of ovarian cancer. Here, the roles of circular_0061140 (circ_0061140) in PTX sensitivity an...

    Authors: Jun Zhu, Jun-e Luo, Yurong Chen and Qiong Wu
    Citation: Journal of Ovarian Research 2021 14:136
  19. The polycystic ovary syndrome (PCOS) is the most common endocrine associated with insulin resistance, even in the absence of overweight. The global lipid profile of the follicular fluid in PCOS with normal wei...

    Authors: Yanna Ban, Haiying Ran, Ying Chen and Li Ma
    Citation: Journal of Ovarian Research 2021 14:135
  20. Polycystic ovary syndrome (PCOS), as one of the significant endocrine disorders, is common among women worldwide. Food insecurity (FI) and unhealthy dietary patterns can negatively affect reproductive health. ...

    Authors: Mahtab Badri-Fariman, Amirmansour Alavi Naeini, Khadijeh Mirzaei, Ashraf Moeini, Mostafa Hosseini, Seyedeh Elaheh Bagheri and Milad Daneshi-Maskooni
    Citation: Journal of Ovarian Research 2021 14:134
  21. The ovaries are the core reproductive organs in women and are critical for maintaining normal reproductive function and endocrine system stability. An ageing C57 mouse model was used to evaluate the efficacy a...

    Authors: Xing-Hua Pan, Xue-Juan Zhang, Xiang Yao, Ni-Ni Tian, Zai-Ling Yang, Kai Wang, Xiang-Qing Zhu, Jing Zhao, Jie He, Xue-Min Cai, Rong-Qing Pang and Guang-Ping Ruan
    Citation: Journal of Ovarian Research 2021 14:133

    The Correction to this article has been published in Journal of Ovarian Research 2023 16:217

  22. Sentinel lymph node (SLN) detection in ovarian cancer is feasible when tracers are injected before the pathological ovary is resected. This study aims to investigate whether the SLN identification is also feas...

    Authors: Pim Laven, Roy Kruitwagen, Petra Zusterzeel, Brigitte Slangen, Toon van Gorp, Jochem van der Pol and Sandrina Lambrechts
    Citation: Journal of Ovarian Research 2021 14:132
  23. The most common gynecologic cancers detected in women in Turkey are uterine cancer, ovarian cancer, and cervical cancer. These data reported that a mean of 3800 individuals were diagnosed with uterine cancer, ...

    Authors: Arash Adamnejad Ghafour, Demet Akdeniz Odemis, Seref Bugra Tuncer, Busra Kurt, Mukaddes Avsar Saral, Seda Kilic Erciyas, Ozge Sukruoglu Erdogan, Betul Celik, Pinar Saip and Hulya Yazici
    Citation: Journal of Ovarian Research 2021 14:131
  24. Polycystic ovary syndrome (PCOS) is one of the most common endocrine diseases in the women at their reproductive age. Nowadays, the use of herbal compounds for lesser side effects, as compared to drug treatme...

    Authors: Vahid Maleki, Amir Hossein Faghfouri, Fatemeh Pourteymour Fard Tabrizi, Jalal Moludi, Sevda Saleh-Ghadimi, Hamed Jafari-Vayghan and Shaimaa A. Qaisar
    Citation: Journal of Ovarian Research 2021 14:130
  25. Epithelial ovarian cancer (EOC) is a heterogeneous disease with diverse clinicopathological features and behaviors, and its heterogeneity may be concerned with the accumulation of multiple somatic oncogenic mu...

    Authors: Takafumi Watanabe, Hideaki Nanamiya, Yuta Endo, Manabu Kojima, Shinji Nomura, Shigenori Furukawa, Shu Soeda, Hirosumi Tamura, Masae Ryufuku, Daisuke Tanaka, Takao Isogai, Jun-ichi Imai, Shinya Watanabe and Keiya Fujimori
    Citation: Journal of Ovarian Research 2021 14:129
  26. Drug resistance and recurrence are main contributors to the poor prognosis of ovarian cancer. Cisplatin is a platinum compound which is widely used in the treatment of various solid tumors including ovarian ca...

    Authors: Yixuan Liu, Keyu Zhu, Xiaolin Guan, Suhong Xie, Yanchun Wang, Ying Tong, Lin Guo, Hui Zheng and Renquan Lu
    Citation: Journal of Ovarian Research 2021 14:128
  27. Infections by the SARS-CoV-2 virus causing COVID-19 are presently a global emergency. The current vaccination effort may reduce the infection rate, but strain variants are emerging under selection pressure. Th...

    Authors: Santosh Kumar Singh, Shailesh Singh and Rajesh Singh
    Citation: Journal of Ovarian Research 2021 14:126
  28. Polycystic ovary syndrome (PCOS) is the most common endocrinopathies affecting the early reproductive age in women, whose pathophysiology perplexes many researchers till today. This syndrome is classically cat...

    Authors: Hiral Chaudhary, Jalpa Patel, Nayan K. Jain and Rushikesh Joshi
    Citation: Journal of Ovarian Research 2021 14:125
  29. There is an urgent need to set up a useful biomarker for ovarian cancer. Galectin-1 is a promising carbohydrate-binding protein which plays a remarkable role in various malignancies yet its clinical significan...

    Authors: Mahak Masoodi, Zafar A. Shah, Afaq H. Beigh, Sheikh Zahoor Ahmad, Abdul Wahid Mir, Besina Yasin, Roohi Rasool, Khalid Z. Masoodi and Gull Mohammad Bhat
    Citation: Journal of Ovarian Research 2021 14:123
  30. Serous ovarian cancer (SOC) is the most common women cancer and the leading cause of cancer-related mortality among the gynaecological malignancies. Although effective chemotherapeutics combined with surgery a...

    Authors: Jing Zhang, Suhong Xie, Lei Zhou, Xiaoyu Tang, Xiaolin Guan, Minjie Deng, Hui Zheng, Yanchun Wang, Renquan Lu and Lin Guo
    Citation: Journal of Ovarian Research 2021 14:122
  31. Ovarian cancer is the most lethal gynecologic malignancy worldwide. Olaparib, an inhibitor of poly (ADP-ribose) polymerase (PARP), is becoming widely used in ovarian cancer treatment. The overall survival of o...

    Authors: Wenjing Hu, Min Li, Youguo Chen and Xinxian Gu
    Citation: Journal of Ovarian Research 2021 14:121
  32. Currently, there is no effective treatment for premature ovarian failure (POF), and stem cell therapy is considered the most promising treatment. Human umbilical cord blood mesenchymal stem cells (hUC-MSCs) ha...

    Authors: Xiaodan Lv, Chunyi Guan, Ying Li, Xing Su, Lu Zhang, Xueqin Wang, Hong-Fei Xia and Xu Ma
    Citation: Journal of Ovarian Research 2021 14:119
  33. Circular RNAs (circRNAs) are gradually reported to be implicated in the development of malignant tumors, including ovarian cancer (OC). This paper intended to explore the function and action mechanism of hsa_c...

    Authors: Xuan Zhou, Jinchi Jiang and Shuaishuai Guo
    Citation: Journal of Ovarian Research 2021 14:118
  34. The aim of this study was to investigate whether pH is stable when transporting ovarian tissue in media buffered with either HEPES or histidine. Furthermore, if the choice of transport media impacts the in vit...

    Authors: Susanne Elisabeth Pors, Stine Gry Kristensen, Dmitry Nikiforov, Linn Salto Mamsen, Jesus Cadenas, Vinnie Hornshøj Greve, Margit Dueholm and Claus Yding Andersen
    Citation: Journal of Ovarian Research 2021 14:116
  35. Tumor microenvironment and chemokines play a significant role in cancer chemoresistance. This study was designed to reveal the important role of CXCL2 in platinum resistance in epithelial ovarian cancer (EOC)....

    Authors: Sipei Nie, Yicong Wan, Hui Wang, Jinhui Liu, Jing Yang, Rui Sun, Huangyang Meng, Xiaolin Ma, Yi Jiang and Wenjun Cheng
    Citation: Journal of Ovarian Research 2021 14:115
  36. Inguinal hernia containing ovary and fallopian tube can be found in paediatric population and is a rare finding in women of reproductive age group. Most of the cases are associated with congenital abnormalitie...

    Authors: Rahul Saini, Lovenish Bains, Tarangpreet Kaur, Pawan Lal, Veer Pal, Mohd Yasir Beg and Daljit Kaur
    Citation: Journal of Ovarian Research 2021 14:114
  37. To investigate changes in peripheral lymphocyte subsets after splenectomy during cytoreductive surgery for advanced or recurrent ovarian cancers.

    Authors: Wei Chen, Shuang Ye, Yutuan Wu, Xuan Pei, Libing Xiang, Bo Ping, Boer Shan and Huijuan Yang
    Citation: Journal of Ovarian Research 2021 14:113
  38. Long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) were reported to be aberrantly expressed and related to the pathogenesis of ovarian cancer. However, the role and regulatory mechanism of MSC-AS1 in ovaria...

    Authors: Yinling Zhao, Donglan Yuan, Dandan Zhu, Tianhui Xu, Aihua Huang, Li Jiang, Chiwen Liu, Hua Qian and Xinhua Bu
    Citation: Journal of Ovarian Research 2021 14:109

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.